WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2002002609) INHIBITORY PAS DOMAIN PROTEIN (IPAS) AND SCREENING METHODS RELATED TO ANGIOGENESIS AND TUMOR PROGRESSION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2002/002609    International Application No.:    PCT/SE2001/001387
Publication Date: 10.01.2002 International Filing Date: 19.06.2001
Chapter 2 Demand Filed:    28.01.2002    
IPC:
C07K 14/47 (2006.01)
Applicants: ANGIOGENETICS AB [SE/SE]; Medicinaregatan 7B P.O Box 440 S-405 30 Göteborg (SE) (For All Designated States Except US).
BERKENSTAM, Anders [SE/SE]; (SE) (For US Only).
BERTILSSON, Göran [SE/SE]; (SE) (For US Only).
POELLINGER, Lorenz [SE/SE]; (SE) (For US Only)
Inventors: BERKENSTAM, Anders; (SE).
BERTILSSON, Göran; (SE).
POELLINGER, Lorenz; (SE)
Agent: HÖGLUND, Lars; Biovitrum AB S-112 76 Stockholm (SE)
Priority Data:
0002551-0 06.07.2000 SE
Title (EN) INHIBITORY PAS DOMAIN PROTEIN (IPAS) AND SCREENING METHODS RELATED TO ANGIOGENESIS AND TUMOR PROGRESSION
(FR) PROTEINE INHIBITRICE DU DOMAINE PAS (IPAS) ET METHODES DE CRIBLAGE RELATIVES A L'ANGIOGENESE ET A LA PROGRESSION D'UNE TUMEUR
Abstract: front page image
(EN)The present invention relates a mammalian polypeptide designated Inhibitory PAS Domain Protein (IPAS) which polypeptide is useful for the inhibition of angiogenesis and/or tumor progression. The invention also relates to screening methods for compounds potentially useful as medicaments for the treatment of medical conditions related to angiogenesis or tumor progression.
(FR)L'invention concerne un polypeptide de mammifère appelé protéine inhibitrice du domaine PAS (IPAS) qui convient pour l'inhibition de l'angiogenèse et/ou de la progression d'une tumeur. L'invention concerne également des méthodes de criblage destinées à des composés potentiellement utiles comme médicaments pour le traitement de troubles médicaux relatifs à l'angiogenèse ou à la progression d'une tumeur.
Designated States: AE, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)